Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tracking and tackling the tumor dynamics clonal evolution: osimertinib rechallenge after interval therapy might be an effective treatment approach in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC).
Metro G, Bonaiti A, Birocchi I, Marasciulo F, Ubaldi M, Metelli N, Minotti V, Addeo A. Metro G, et al. Among authors: bonaiti a. J Thorac Dis. 2022 Apr;14(4):816-819. doi: 10.21037/jtd-22-98. J Thorac Dis. 2022. PMID: 35572898 Free PMC article. No abstract available.
Inflamed Tumor Phenotype as Predictor of Long-Term Response to Pembrolizumab in an EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patient with Acquired Resistance to Afatinib: a Case Report and Review of the Literature.
Baglivo S, Mandarano M, Bellezza G, Minotti V, Bonaiti A, Fischer MJ, Birocchi I, Roila F, Metelli N, Ludovini V, Metro G. Baglivo S, et al. Among authors: bonaiti a. Oncol Ther. 2022 Jun;10(1):291-300. doi: 10.1007/s40487-022-00183-7. Epub 2022 Jan 23. Oncol Ther. 2022. PMID: 35066813 Free PMC article.